Personalized Cannabinoid Formulation System

A system for tailoring cannabinoid formulations to individual genotypes, medical histories, and preferred cannabinoid ratios, ensuring optimal efficacy and minimizing adverse effects.

The original cannabinoid formulations patent (Cannabinoid formulations) has inherent limitations, including the lack of personalization and limited consideration of individual genetic variations. This inventive concept addresses these limitations by incorporating genetic profiling, formulation databases, and recommendation engines to provide personalized cannabinoid formulations.

The system consists of a genetic profiling module, a formulation database, and a recommendation engine. The genetic profiling module identifies an individual's genotype, focusing on polymorphisms relevant to cannabinoid metabolism and response. The formulation database contains a plurality of formulations with varying cannabinoid ratios, each optimized for specific genotypes and medical conditions. The recommendation engine selects a formulation based on the individual's genotype, medical history, and preferred cannabinoid ratio. The system can also adjust the formulation based on the individual's response to the formulation, ensuring optimal efficacy and minimizing adverse effects.

The new claims introduce a paradigm shift in cannabinoid formulations by incorporating genetic profiling, formulation databases, and recommendation engines. This personalized approach is non-obvious and novel compared to the original patent, which focused solely on cannabinoid ratios and terpene profiles.

Alternative embodiments may include the integration of artificial intelligence, machine learning algorithms, or blockchain technology to enhance the recommendation engine's accuracy and security. Variations may include the use of different genetic markers, additional cannabinoids, or alternative delivery methods.

The personalized cannabinoid formulation system has significant commercial potential in the medical cannabis industry, particularly in the areas of chronic pain management, anxiety treatment, and personalized medicine. The system can be marketed as a premium service, offering patients a tailored approach to cannabinoid therapy.